Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non-cash Items (2023 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Non-cash Items for 3 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 219900.0% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, up 219900.0% year-over-year, with the annual reading at $6.6 million for FY2025, 89.23% up from the prior year.
  • Non-cash Items for Q4 2025 was $6.6 million at Orchestra BioMed Holdings, up from $4.2 million in the prior quarter.
  • The five-year high for Non-cash Items was $10.6 million in Q3 2023, with the low at $3000.0 in Q4 2024.
  • Average Non-cash Items over 3 years is $4.4 million, with a median of $3.5 million recorded in 2024.
  • The sharpest move saw Non-cash Items tumbled 99.96% in 2024, then soared 219900.0% in 2025.
  • Over 3 years, Non-cash Items stood at $8.2 million in 2023, then plummeted by 99.96% to $3000.0 in 2024, then skyrocketed by 219900.0% to $6.6 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $6.6 million, $4.2 million, and $687000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.